STING1 and cancer: Increased activation of the cGAS-STING pathway in cancer cells limits tumorigenesis, through the upregulation of inflammatory genes, which leads to the release of inflammatory cytokines and chemokines that slow down tumor growth and recruit anti-tumor immune cells (21).